📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 22:32
78 analysed today
FollowTelegram
78
Today
150,517
All-time analysed
43,117
Positive
6,694
Negative
91,947
Neutral
8,691
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
10 announcements match the current filters (relevance ≥ 5).
UNIVPHOTO Q1 Results: Net Profit of ₹6.95 Cr Supported by ₹7.44 Cr Other Income
Universus Photo Imagings reported a standalone net profit of ₹6.95 Cr for Q1 FY27 (June 2026), down from ₹8.93 Cr in the year-ago period. Revenue from operations grew slightly to ₹5.48 Cr compared to ₹4.97 Cr in June 2025, but the company remains heavily dependent on 'Other Income' (₹7.44 Cr), which exceeded core operational revenue. The board also approved the re-appointment of Mr. Sanjeev Aggarwal as an Independent Director for a second 5-year term. Despite the quarterly profit, the company faces structural challenges as its core X-ray film business is threatened by digital diagnostics.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and confirmed the re-appointment of an Independent Director and Internal Auditor.
Why it mattersThe results show a return to quarterly profit after a heavy TTM loss of ₹80 Cr, but the low operational revenue (₹5.48 Cr) relative to the ₹521 Cr market cap suggests the valuation is driven by assets or investments rather than core business growth.
Q1 Revenue from Operations: ₹5.48 CrQ1 Other Income: ₹7.44 CrQ1 Net Profit: ₹6.95 CrOther Income as % of Total Revenue: 57.6%TTM Net Profit: ₹-80 Cr
📅 Short termThe stock may see neutral to slightly positive sentiment due to the reported quarterly profit, though the reliance on non-core income limits the quality of the earnings.
📈 Long termThe long-term outlook remains cautious as the company must successfully transition its business model to offset the decline in physical X-ray film demand.
⚠ Risk flags
- Core business obsolescence
- High dependence on non-operating income
- Small operational scale relative to market capitalization
Key Highlights
Net Profit for the quarter ended June 30, 2026, stood at ₹6.95 Cr.
Revenue from operations was ₹5.48 Cr, representing approximately 28% of TTM revenue.
Other Income of ₹7.44 Cr accounted for 57.6% of the total revenue for the quarter.
Total expenses decreased to ₹4.71 Cr from ₹5.54 Cr in the corresponding quarter of the previous year.
Re-appointment of Independent Director Sanjeev Aggarwal approved for a 5-year term starting November 13, 2026.
👀 What to Watch
Investors should monitor the source of 'Other Income' and look for updates on the company's pivot to health-tech startups, as the core business continues to struggle with technological obsolescence.
Universus Photo Q1 FY27 Revenue at ₹5.48 Cr; Re-appoints Independent Director for 5 Years
Universus Photo Imagings reported standalone Q1 FY27 revenue of ₹5.48 Cr, a 10% increase from ₹4.97 Cr in Q1 FY26. Standalone profit for the period stood at ₹6.95 Cr, down from ₹8.93 Cr YoY, with profitability heavily supported by 'Other Income' of ₹7.44 Cr which exceeded core operational revenue. The board also approved the re-appointment of Mr. Sanjeev Aggarwal as an Independent Director for a second five-year term starting November 2026. The company remains in a structural transition as digitalization continues to impact its core X-ray film business.
Confidence: HIGH
What changedThe company has reported its first-quarter results for FY27 and confirmed the continuation of key board and audit personnel.
Why it mattersThe results confirm the company's ongoing reliance on non-operational income (Other Income) to sustain profitability while its core manufacturing business remains stagnant due to industry-wide digitalization.
Q1 FY27 Standalone Revenue: ₹5.48 CrQ1 FY27 Other Income: ₹7.44 CrQ1 FY27 Standalone PAT: ₹6.95 CrRevenue vs Market Cap: ~1.05%Independent Director Term: 5 Years
📅 Short termThe stock is likely to remain neutral in the short term as the earnings reflect a small-scale operation heavily dependent on non-core income.
📈 Long termLong-term value depends entirely on the company's ability to redeploy its significant net worth (₹668 Cr) into new growth areas, as the traditional X-ray film market is shrinking.
⚠ Risk flags
- Technological obsolescence of core X-ray film products
- High reliance on non-operational income for profitability
- Negative TTM consolidated PAT of ₹-80 Cr
Key Highlights
Standalone revenue from operations for Q1 FY27 was ₹5.48 Cr compared to ₹4.97 Cr in Q1 FY26.
Other Income of ₹7.44 Cr contributed significantly to the total revenue of ₹12.92 Cr in Q1 FY27.
Standalone Profit for the period was ₹6.95 Cr, a decline from ₹8.93 Cr in the corresponding previous quarter.
Mr. Sanjeev Aggarwal re-appointed as Independent Director for a 5-year term from Nov 13, 2026, to Nov 12, 2031.
Mr. Suresh Kumar re-appointed as Internal Auditor for the financial year 2026-27.
👀 What to Watch
Investors should monitor the company's progress in pivoting toward health-tech startups, as the core X-ray film business (₹19 Cr TTM revenue) is small relative to its ₹668 Cr net worth and faces technological obsolescence.
Rs 6.95 Cr Net Profit: UNIVPHOTO Reports Q1 FY27 Results and Board Appointments
Universus Photo Imagings reported a standalone net profit of Rs 6.95 Cr for the quarter ended June 30, 2026, a 22% decline from Rs 8.93 Cr in the same period last year. While revenue from operations grew slightly by 10.2% YoY to Rs 5.48 Cr, total revenue was impacted by a significant drop in 'Other Income' to Rs 7.44 Cr from Rs 11.04 Cr. The company continues to rely heavily on non-operational income, which accounted for 57.6% of total revenue this quarter. The board also confirmed the re-appointment of an Independent Director for a five-year term and an Internal Auditor for FY27.
Confidence: HIGH
What changedThe company reported its first-quarter results for FY27 and formalized the re-appointment of key management and audit personnel.
Why it mattersThe results highlight the ongoing challenge of technological obsolescence in the core X-ray film business, with the company's profitability currently sustained by financial assets rather than core sales.
Q1 Net Profit: Rs 6.95 CrQ1 Revenue from Ops: Rs 5.48 CrOther Income % of Total Revenue: 57.6%TTM Revenue vs Net Worth: ~2.8%
📅 Short termThe stock may remain range-bound as the decline in YoY profitability is offset by the fact that the company remains profitable despite a shrinking core market.
📈 Long termThe long-term outlook depends entirely on the successful deployment of its Rs 668 Cr net worth into new growth areas, as the traditional medical film business faces digital replacement.
⚠ Risk flags
- Technological obsolescence of core products
- High dependence on non-operating income
- Declining year-on-year profitability
Key Highlights
Standalone Net Profit stood at Rs 6.95 Cr for Q1 FY27 compared to Rs 8.93 Cr in Q1 FY26
Revenue from operations increased to Rs 5.48 Cr from Rs 4.97 Cr in the year-ago quarter
Other Income contributed Rs 7.44 Cr, significantly exceeding operational revenue of Rs 5.48 Cr
Total expenses were reduced to Rs 4.71 Cr from Rs 5.54 Cr YoY
Re-appointment of Mr. Sanjeev Aggarwal as Independent Director for a 5-year term until November 2031
👀 What to Watch
Monitor the company's progress in pivoting away from its obsolete X-ray film business toward the health-tech ecosystem. Investors should track whether operational revenue can eventually replace the high reliance on investment-led 'Other Income'.
SEBI Issues Show Cause Notice to Universus Photo Imagings Over Governance and Transactions
Universus Photo Imagings Limited received a Show Cause Notice (SCN) from SEBI on August 06, 2026, regarding observations on specific transactions and corporate governance issues. The notice is issued under multiple sections of the SEBI Act, 1992, including those related to fraudulent and unfair trade practices (15HA) and general penalties (15HB). The SCN involves the company, its promoters, and key management personnel. While no financial penalty has been quantified yet, the regulatory scrutiny is significant given the company's small TTM revenue of Rs 19 Cr and substantial TTM losses of Rs 80 Cr.
Confidence: HIGH
What changedSEBI has formally initiated a show-cause process against the company and its leadership regarding governance and transaction-related observations.
Why it mattersRegulatory scrutiny on governance is a major risk factor for a company already facing a declining core business (X-ray films) and heavy operational losses. It could impact the company's ability to pivot its business model or manage its Rs 668 Cr net worth.
Date of SCN receipt: August 06, 2026TTM Revenue: Rs 19 CrTTM Net Profit: Rs -80 CrNet Worth: Rs 668 CrPromoter Holding: 74.55%
📅 Short termThe stock may face downward pressure due to the uncertainty and negative sentiment associated with a SEBI show-cause notice involving promoters.
📈 Long termGovernance issues can lead to structural de-rating and legal complications that may hinder the company's strategic shift toward health-tech startups.
⚠ Risk flags
- Regulatory action
- Governance concerns
- Unquantified financial penalty
- Promoter/KMP involvement in SCN
Key Highlights
Show Cause Notice received from SEBI on August 06, 2026, via email.
Notice issued under Sections 11(1), 11(4), 11B(1), 15HA, 15HB, and 15A(a) of the SEBI Act, 1992.
The investigation pertains to certain transactions and matters of corporate governance involving promoters and KMPs.
Company's TTM revenue is just Rs 19 Cr, making any potential regulatory penalty highly material to its financial health.
The company is currently in the process of filing a reply to the regulatory authority.
👀 What to Watch
Monitor for the company's formal response to SEBI and any subsequent adjudication orders that may impose penalties or restrictions. Investors should evaluate the 'governance' risk in the context of the company's high promoter holding of 74.55%.
Universus Photo FY26 Net Profit Drops 39% to ₹19.26 Cr; Revenue from Operations Down 24%
Universus Photo Imagings Limited reported a significant decline in its financial performance for the fiscal year ended March 31, 2026. Annual net profit fell to ₹1,926 lakhs from ₹3,175 lakhs in the previous year, while revenue from operations decreased from ₹2,460 lakhs to ₹1,878 lakhs. The company's bottom line remains heavily dependent on 'Other Income' (₹2,094 lakhs), which also saw a sharp reduction from the previous year's ₹4,223 lakhs.
Key Highlights
Annual Net Profit declined by 39.3% YoY to ₹1,926 lakhs in FY26.
Revenue from operations for FY26 fell 23.6% YoY to ₹1,878 lakhs.
Other Income, a primary profit driver, halved from ₹4,223 lakhs in FY25 to ₹2,094 lakhs in FY26.
Earnings Per Share (EPS) dropped significantly to ₹17.59 from ₹29.00 in the previous fiscal year.
Non-current investments increased to ₹400.86 crore, representing the bulk of the company's asset base.
👀 What to Watch
Investors should exercise caution as the company's core operations are shrinking and profitability is largely driven by investment/other income rather than business growth. Monitor the quality of the investment portfolio which constitutes the majority of the balance sheet.
Universus Photo Imagings: NCLAT Dismisses Shareholder Appeal; NCLT Order Remains in Force
Universus Photo Imagings Limited has announced that the National Company Law Appellate Tribunal (NCLAT) has dismissed an appeal filed by a shareholder, Mr. Ankit Jain. The appeal challenged a previous NCLT Allahabad Bench order dated October 15, 2025, which was originally ruled in favor of the company. With the NCLAT dismissing the appeal as withdrawn on April 16, 2026, the original favorable order remains fully operative. The company has confirmed that there are no financial implications or penalties resulting from this legal development.
Key Highlights
NCLAT dismissed the appeal filed by shareholder Mr. Ankit Jain as withdrawn on April 16, 2026.
The original NCLT Allahabad Bench order dated October 15, 2025, in favor of the company, remains in force.
Management confirmed zero financial implications or penalties arising from this legal proceeding.
All pending applications related to Company Petition No. 49/ALD/2022 have been officially disposed of.
👀 What to Watch
Investors should view this as a positive development as it resolves a legal overhang and confirms the validity of a prior favorable court ruling. No immediate action is required as the company's financial position remains unaffected.
Universus Photo Imagings Wins Legal Battle as Shareholder Withdraws NCLAT Appeal
Universus Photo Imagings Limited has announced the successful resolution of a legal dispute with a shareholder, Mr. Ankit Jain. Following an initial victory at the NCLT Allahabad on October 15, 2025, the shareholder had filed an appeal with the NCLAT. On April 16, 2026, the NCLAT allowed the withdrawal of this appeal by the petitioner, effectively dismissing the case. This outcome ensures that the previous ruling in favor of the company remains operative and finalizes the litigation process.
Key Highlights
NCLAT allowed the withdrawal of the appeal filed by shareholder Mr. Ankit Jain on April 16, 2026
The original NCLT Allahabad order dated October 15, 2025, in favor of the company remains fully operative
The dismissal of the appeal removes a significant legal overhang and potential liability for the company
The company is currently awaiting the formal written order from the NCLAT for final record-keeping
👀 What to Watch
The withdrawal of the appeal is a positive development as it concludes a period of legal uncertainty. Investors can view this as a clearance of regulatory and legal hurdles regarding the company's internal governance.
Universus Photo Q3 Results: Consolidated Net Loss of ₹23.89 Cr Amid Associate Losses
Universus Photo Imagings reported a weak performance for Q3 FY26, with standalone revenue declining 20% YoY to ₹3.84 crore. The consolidated results were severely impacted by a ₹26.91 crore loss from its foreign associate, JPF Netherlands B.V., leading to a total consolidated net loss of ₹23.89 crore for the quarter. For the nine-month period, the company has swung to a massive consolidated loss of ₹66.87 crore, compared to a profit of ₹108.06 crore in the previous year. Standalone profitability also weakened, with EPS dropping to ₹2.74 from ₹4.19 YoY.
Key Highlights
Consolidated net loss of ₹23.89 crore reported for Q3 FY26.
Standalone revenue from operations fell 20% YoY to ₹3.84 crore from ₹4.80 crore.
Share of loss from foreign associate JPF Netherlands B.V. stood at ₹26.91 crore for the quarter.
Nine-month consolidated performance reversed from a profit of ₹108.06 crore last year to a loss of ₹66.87 crore.
Standalone Net Profit for the quarter decreased to ₹3.02 crore from ₹4.58 crore in the year-ago period.
👀 What to Watch
Investors should exercise caution as the consolidated performance is being heavily dragged down by significant losses in the foreign associate company. It is advisable to wait for clarity on the turnaround of the Netherlands-based associate before considering new positions.
Universus Photo Q3 Results: Standalone Profit ₹3.02 Cr, Consolidated Loss ₹23.89 Cr
Universus Photo Imagings reported a standalone net profit of ₹3.02 crore for Q3 FY26, a decline from ₹4.58 crore in the same quarter last year. On a consolidated basis, the company posted a net loss of ₹23.89 crore, primarily driven by a significant loss of ₹26.91 crore from its foreign associate, JPF Netherlands B.V. Total consolidated revenue for the quarter stood at ₹8.07 crore, down from ₹9.46 crore YoY. The nine-month consolidated performance shows a sharp swing to a loss of ₹66.87 crore compared to a profit of ₹108.06 crore in the previous year.
Key Highlights
Standalone revenue decreased 20% YoY to ₹3.84 crore from ₹4.80 crore.
Consolidated net loss for Q3 FY26 stood at ₹23.89 crore, though narrowed from a loss of ₹88.98 crore in Q3 FY25.
Share of loss from associate company JPF Netherlands B.V. impacted the bottom line by ₹26.91 crore this quarter.
Nine-month consolidated loss reached ₹66.87 crore against a profit of ₹108.06 crore in the prior year period.
Standalone EPS for the quarter dropped to ₹2.74 from ₹4.19 in the year-ago period.
👀 What to Watch
Investors should exercise caution as the company's consolidated performance is severely impacted by heavy losses in its Dutch associate. Monitor the standalone revenue decline and any turnaround signs in the associate company before considering new positions.
Universus Photo to Subscribe to Rights Issue of Associate JPF Netherlands B.V. at Euro 3/Share
Universus Photo Imagings Limited has approved the subscription to a rights issue of its associate company, JPF Netherlands B.V., at a price of Euro 3 per share. The target entity is a significant player in the BOPP and flexible packaging films industry, reporting a turnover of Euro 492.65 million for FY 2024-25. Universus currently maintains a 39.87% stake in the company, and this move ensures it maintains its strategic interest. The transaction is a cash consideration and is expected to be completed within the next 1-2 months.
Key Highlights
Subscription to rights issue of associate company JPF Netherlands B.V. at Euro 3 per share
Target entity JPF Netherlands B.V. reported a turnover of Euro 492.65 million in FY 2024-25
Universus Photo Imagings currently holds a 39.87% shareholding in the associate company
The acquisition is a cash-based transaction expected to conclude within 1-2 months
👀 What to Watch
Investors should view this as a strategic move to support a high-turnover associate in the flexible packaging sector. Monitor the impact on the company's cash reserves and the future dividend or growth contributions from this associate.
